SLC35C1 and central nervous system cancer: The results displayed that in glioma, the high expression of SLC35C1 was mainly concentrated in TNFA_SIGNALING_VIA_NFKB, GLYCOLYSIS, APICAL_JUNCTION and other signaling pathways (Fig. 9A).